-$0.17 Earnings Per Share Expected for Olink Holding AB (publ) (NASDAQ:OLK) This Quarter

Wall Street brokerages expect Olink Holding AB (publ) (NASDAQ:OLKGet Rating) to announce earnings of ($0.17) per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Olink Holding AB (publ)’s earnings, with the lowest EPS estimate coming in at ($0.17) and the highest estimate coming in at ($0.16). Olink Holding AB (publ) reported earnings per share of ($0.48) during the same quarter last year, which indicates a positive year over year growth rate of 64.6%. The company is expected to announce its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Olink Holding AB (publ) will report full year earnings of ($0.41) per share for the current fiscal year, with EPS estimates ranging from ($0.43) to ($0.38). For the next year, analysts anticipate that the business will report earnings of ($0.17) per share, with EPS estimates ranging from ($0.18) to ($0.16). Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that cover Olink Holding AB (publ).

Olink Holding AB (publ) (NASDAQ:OLKGet Rating) last issued its quarterly earnings data on Monday, February 14th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.09). Olink Holding AB (publ) had a negative net margin of 40.37% and a negative return on equity of 7.68%. The business had revenue of $43.68 million for the quarter, compared to analysts’ expectations of $43.50 million.

Several equities research analysts have weighed in on the company. Morgan Stanley cut their price target on Olink Holding AB (publ) from $33.00 to $32.00 and set an “equal weight” rating on the stock in a research report on Monday, February 14th. The Goldman Sachs Group cut their price target on Olink Holding AB (publ) from $34.00 to $20.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 13th. Zacks Investment Research raised Olink Holding AB (publ) from a “strong sell” rating to a “hold” rating in a research report on Wednesday. Finally, BTIG Research dropped their target price on Olink Holding AB (publ) from $44.00 to $37.00 in a research report on Wednesday, February 16th.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Raymond James & Associates increased its stake in Olink Holding AB (publ) by 5.9% during the third quarter. Raymond James & Associates now owns 8,796 shares of the company’s stock worth $213,000 after acquiring an additional 487 shares during the last quarter. Jump Financial LLC acquired a new stake in Olink Holding AB (publ) during the third quarter worth $226,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Olink Holding AB (publ) during the fourth quarter worth $178,000. Marshall Wace LLP acquired a new stake in Olink Holding AB (publ) during the third quarter worth $287,000. Finally, Geode Capital Management LLC increased its stake in Olink Holding AB (publ) by 75.1% during the fourth quarter. Geode Capital Management LLC now owns 19,562 shares of the company’s stock worth $356,000 after acquiring an additional 8,387 shares during the last quarter. 26.67% of the stock is currently owned by institutional investors and hedge funds.

Shares of OLK stock opened at $14.44 on Tuesday. The firm has a market capitalization of $1.72 billion and a price-to-earnings ratio of -20.93. The business has a fifty day moving average of $16.85 and a 200 day moving average of $19.95. Olink Holding AB has a 1 year low of $10.64 and a 1 year high of $40.88.

About Olink Holding AB (publ) (Get Rating)

Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on.

Read More

Get a free copy of the Zacks research report on Olink Holding AB (publ) (OLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Olink Holding AB (publ) (NASDAQ:OLK)

Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.